Premium
Salvage therapy with basiliximab and etanercept for severe steroid‐refractory acute graft‐versus‐host disease
Author(s) -
Freyer Craig W.,
Gier Shan,
Carulli Alison,
Gill Saar I.,
Hexner Elizabeth O.,
Loren Alison W.,
Martin Mary Ellen,
Porter David L.
Publication year - 2022
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.26568
Subject(s) - medicine , basiliximab , etanercept , ruxolitinib , salvage therapy , refractory (planetary science) , transplantation , graft versus host disease , surgery , gastroenterology , chemotherapy , tacrolimus , bone marrow , myelofibrosis , tumor necrosis factor alpha , physics , astrobiology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom